TECELRA Trademark
Trademark Overview
On Thursday, October 26, 2023, a trademark application was filed for TECELRA with the United States Patent and Trademark Office. The USPTO has given the TECELRA trademark a serial number of 98241205. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, October 29, 2024. This trademark is owned by Adaptimmune Limited. The TECELRA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Cell therapy pharmaceutical preparations; immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
Cell therapy medical treatment services; medical services, namely, immunotherapy services; medical services, namely, medical treatment and immunetherapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
General Information
| Serial Number | 98241205 |
| Word Mark | TECELRA |
| Filing Date | Thursday, October 26, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized "TECELRA" wording next to a stylized design of a polygon with curved sides and twisted at the bottom. |
| Goods and Services | Cell therapy pharmaceutical preparations; immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Cell therapy medical treatment services; medical services, namely, immunotherapy services; medical services, namely, medical treatment and immunetherapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 1, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Adaptimmune Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | Oxford OX144RX
GB |
Trademark Events
| Event Date | Event Description |
| Monday, October 30, 2023 | NEW APPLICATION ENTERED |
| Wednesday, November 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 2, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, June 10, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 12, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 12, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, July 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 23, 2024 | ASSIGNED TO LIE |
